Vape shop and consumer activity during COVID-19 non-essential business closures in the USA
Open Access
- 19 October 2020
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 30 (e1), e41-e44
- https://doi.org/10.1136/tobaccocontrol-2020-056171
Abstract
Introduction Vaping and vape shops pose risk for COVID-19 and its transmission. Objectives We examined vape shop non-compliance with state-ordered business closures during COVID-19, changes in their marketing and experiences among consumers. Methods As part of a longitudinal study of vape retail in six metropolitan statistical areas (MSAs; Atlanta, Boston, Minneapolis, Oklahoma City, San Diego and Seattle), we conducted: (1) legal research to determine whether statewide COVID-19 orders required vape shops to close; (2) phone-based and web-based surveillance to assess vape shop activity in March–June 2020 during shelter-in-place periods; and (3) a concurrent online survey of e-cigarette users about their experiences with vape retail. Results Non-essential business closure varied in timing/duration across states and applied to vape shops in California, Massachusetts, Minnesota, Oklahoma (for a brief period) and Washington (Georgia’s orders were ambiguous). Surveillance analysis focused on the five MSAs in these states. Of 156 vape shops, 53.2% were open as usual, 11.5% permanently closed and 3.8% temporarily closed; 31.4% offered pick-up/delivery services. Among survey respondents (n=354, Mage=23.9±4.6; 46.9% male, 71.8% white, 13.0% Hispanic), 27.4% worried their vape shop would close/go out of business during COVID-19; 7.3% said their vape shop did so. Few noticed increases in vape product delivery options (7.3%), discounts/price promotions (9.9%) and/or prices (9.3%). While 20.3% stockpiled vape products, 20.3% tried to reduce use and 15.8% tried to quit. Conclusions Many vape shops were non-compliant with state COVID-19 orders. E-cigarette users were as likely to stockpile vape products as to attempt to reduce or quit using e-cigarettes.Keywords
Funding Information
- Division of Cancer Prevention, National Cancer Institute (R01CA215155-01A1)
This publication has 14 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Change in Tobacco and Electronic Cigarette Use and Motivation to Quit in Response to COVID-19Nicotine & Tobacco Research, 2020
- Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1The New England Journal of Medicine, 2020
- COVID-19 and SmokingNicotine & Tobacco Research, 2020
- COVID-19 and smoking: A systematic review of the evidenceTobacco Induced Diseases, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Exploring the Point-of-Sale Among Vape Shops Across the United States: Audits Integrating a Mystery Shopper ApproachNicotine & Tobacco Research, 2020
- Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agentsJournal of Hospital Infection, 2020
- Marketing activities of vape shops across racial/ethnic communitiesTobacco Prevention & Cessation, 2016